1.1Endoscopic bile duct clearance
A side-viewing endoscope provides access to the bile duct through its opening in the duodenum. A retrieval balloon or basket sweeps adult flukes out of an obstructed duct and restores bile drainage.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A side-viewing endoscope provides access to the bile duct through its opening in the duodenum. A retrieval balloon or basket sweeps adult flukes out of an obstructed duct and restores bile drainage.
A veterinary suspension delivers a chlorinated benzothiazole with a methylsulfonyl substituent. The compound disrupts energy metabolism in susceptible adult liver flukes in the bile ducts.
An ortho hydroxyl group on the benzoyl ring and electron-withdrawing substituents support proton transport across mitochondrial membranes. The salicylanilide dissipates the proton gradient and reduces ATP production in susceptible flukes.
The nitro and nitrile groups increase the acidity of the phenolic hydroxyl. The compound shuttles protons across the inner mitochondrial membrane and reduces ATP production in susceptible liver flukes.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
The mammal absorbs the benzimidazole and oxidizes its thioether group to a sulfoxide. The active metabolite disrupts tegument integrity and movement in susceptible immature and adult flukes.
Chlorine occupies the R2 position, and a trifluoromethyl group occupies R4. Hydrogen occupies R1, R3, and R5, and oxygen occupies X.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The present invention provides compounds as described below, pharmaceutical compositions comprising the compounds, their use for increasing the activity of glucokinase, their use in preparation of a medicament for treating said diseases and conditions and the use of compounds or pharmaceutical preparations of the present invention for treating said diseases and conditions as well as methods for treating said diseases and conditions, which methods comprise administering to a sA · US 7,541,373 B2 · ¶ 23
The present invention provides a method of activating glucokinase, comprising the step of administering to a mammal in need thereof a pharmacologically effective amount of a compound according to the present invention.B · US 2011/0301158 A1 · ¶ 1870
An empty cell means only that no passage was reproduced there.
This invention relates to compounds which are activators of glucokinase (GK), which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.A · US 7,541,373 B2 · ¶ 2
Since existing forms of therapy of diabetes does not lead to sufficient glycaemic control and therefore are unsatisfactory, there is a great demand for novel therapeutic approaches.A · US 7,541,373 B2 · ¶ 7
This invention relates to compounds which are activators of glucokinase (GK), which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.B · US 2011/0301158 A1 · ¶ 2
Since existing forms of therapy of diabetes does not lead to sufficient glycaemic control and therefore are unsatisfactory, there is a great demand for novel therapeutic approaches.B · US 2011/0301158 A1 · ¶ 7
patent.fyi, US 2026/0355163 A1, claim 1, first published 2026-11-19T08:28:42-05:00, https://patent.fyi/US20260355163/, SHA-256 c1eccdf177e1538094e0a21212551ee8583d5b61c914fe4d2207812f56471eec